Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab: a Pilot Study

NCT03074942 is registered in ClinicalTrials.gov with Sociedad Española de Neumología y Cirugía Torácica as lead sponsor.

NCT NCT03074942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03074942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab: a Pilot Study
Lead sponsor
Sociedad Española de Neumología y Cirugía Torácica
Phase
Phase 2
Overall status
Completed
Start date
April 20, 2017
Completion date
April 30, 2018
Enrollment
30 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma